EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C24H23N3O2 |
| Net Charge | 0 |
| Average Mass | 385.467 |
| Monoisotopic Mass | 385.17903 |
| SMILES | C=CC(C)(C)c1nc2ccccc2c1/C=C1/C(=O)Nc2ccccc2C(=O)N1C |
| InChI | InChI=1S/C24H23N3O2/c1-5-24(2,3)21-17(15-10-6-8-12-18(15)25-21)14-20-22(28)26-19-13-9-7-11-16(19)23(29)27(20)4/h5-14,25H,1H2,2-4H3,(H,26,28)/b20-14- |
| InChIKey | DLKHYDICDGRHSE-ZHZULCJRSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Aspergillus fischeri (ncbitaxon:36630) | - | PubMed (32315839) |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Fischeramide B (CHEBI:215486) is a benzodiazepine (CHEBI:22720) |
| IUPAC Name |
|---|
| (3Z)-4-methyl-3-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]-1H-1,4-benzodiazepine-2,5-dione |